Indian drugmaker Lupin Ltd on Monday said its second-quarter profit fell about 31%, but the results were slightly above estimates.
The company's profit came in at Rs 455 crore ($70.14 million) for the quarter ended September 30, compared with Rs 662 crore a year earlier.
Analysts on average had expected a profit of Rs 433 crore, according to Thomson Reuters data.
($1 = Rs 64.8700)